Silo Pharma, Inc. (SILO)
2.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
2.15
0.00 (0.00%)
After-Hours: 20:00
Silo Pharma Market Cap : 2.426M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 2.426M |
| September 08, 2026 | 2.573M |
| September 04, 2026 | 2.709M |
| September 03, 2026 | 2.765M |
| September 02, 2026 | 2.822M |
| September 01, 2026 | 2.754M |
| August 31, 2026 | 2.799M |
| August 28, 2026 | 2.867M |
| August 27, 2026 | 2.867M |
| August 26, 2026 | 2.822M |
| August 25, 2026 | 2.923M |
| August 24, 2026 | 2.912M |
| August 21, 2026 | 2.991M |
| August 20, 2026 | 3.092M |
| August 19, 2026 | 3.228M |
| August 18, 2026 | 3.465M |
| August 17, 2026 | 3.465M |
| August 14, 2026 | 3.612M |
| August 13, 2026 | 3.634M |
| August 12, 2026 | 3.493M |
| August 11, 2026 | 4.018M |
| August 10, 2026 | 4.099M |
| August 07, 2026 | 4.050M |
| August 06, 2026 | 5.064M |
| August 05, 2026 | 4.999M |
| Date | Value |
|---|---|
| August 04, 2026 | 4.988M |
| August 03, 2026 | 4.685M |
| July 31, 2026 | 4.544M |
| July 30, 2026 | 4.609M |
| July 29, 2026 | 4.663M |
| July 28, 2026 | 4.836M |
| July 27, 2026 | 4.771M |
| July 24, 2026 | 4.847M |
| July 23, 2026 | 4.836M |
| July 22, 2026 | 4.999M |
| July 21, 2026 | 5.108M |
| July 20, 2026 | 5.097M |
| July 17, 2026 | 5.270M |
| July 16, 2026 | 5.183M |
| July 15, 2026 | 5.286M |
| July 14, 2026 | 5.563M |
| July 13, 2026 | 5.726M |
| July 10, 2026 | 6.181M |
| July 09, 2026 | 8.382M |
| July 08, 2026 | 7.352M |
| July 07, 2026 | 6.138M |
| July 06, 2026 | 6.745M |
| July 02, 2026 | 6.702M |
| July 01, 2026 | 6.691M |
| June 30, 2026 | 6.734M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.775B |
| Alnylam Pharmaceuticals, Inc. | 33.10B |
| Anika Therapeutics, Inc. | 280.71M |
| Savara, Inc. | 1.093B |
| Vericel Corp. | 1.938B |
Market Cap Related Metrics
| PS Ratio | 35.00 |
| Price to Book Value | 0.4966 |
| Price | 2.15 |
| Earnings Yield | -248.3% |